Found 95 articles for: "Dermatitis"
Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert Opinion
November 2026 | Volume 25 | Issue 11 | Original Article | 1019 | Copyright © November 2026
Background: Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease characterized by greasy, scaly plaques on the scalp or body, often with pruritus and impaired ...
Read MoreCicatricial Ectropion in the Setting of IL-13 Inhibition
October 2026 | Volume 25 | Issue 10 | Case Reports | 971 | Copyright © October 2026
Introduction: Interleukin (IL)-13 is a key mediator of type 2 inflammation and an important therapeutic target in atopic dermatitis (AD). Although IL-4/IL-13 and IL-13 inhibitors...
Read MoreNordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 949 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic disease with a dysfunctional skin barrier, requiring continuous management to reduce symptoms and prevent flares. Topical treatmen...
Read MoreSAIGE III: The Role of Environmental Factors in the Development and Severity of Atopic Dermatitis in Young Children
October 2026 | Volume 25 | Issue 10 | Original Article | 935 | Copyright © October 2026
Background: Atopic dermatitis (AD) often manifests in infancy or early childhood, with significant impacts on quality of life and potential persistence into adulthood. Environmen...
Read MoreOff-Label Uses of Nemolizumab: A Narrative Review
October 2026 | Volume 25 | Issue 10 | Original Article | 956 | Copyright © October 2026
Background: Nemolizumab, a humanized monoclonal antibody targeting interleukin-31 receptor α (IL-31Rα), is approved for atopic dermatitis (AD) and prurigo nodularis (...
Read MoreA Narrative Review of Seven Off-Label Treatment Options for Seborrheic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 943 | Copyright © October 2026
Background: Seborrheic dermatitis (SD) is a chronic inflammatory skin condition driven by overactive sebaceous glands, Malassezia colonization, immune dysfunction, and epidermal ...
Read MoreThe Essential Role of Topical Targeted Therapy in Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 898 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by immune dysregulation, epidermal barrier dysfunction, microbiome imbalance, pruritus, and xero...
Read MoreContact Allergens Associated With Nummular Eczema: A Systematic Review
October 2026 | Volume 25 | Issue 10 | Original Article | 914 | Copyright © October 2026
Background: Nummular eczema (NE) is a prevalent and chronic inflammatory dermatosis marked by pruritic, coin-shaped eczematous plaques. Contact allergen sensitization may play a ...
Read MorePulsed Dye Laser for Sensory Dysesthesias Associated With Chronic Radiation Dermatitis
October 2026 | Volume 25 | Issue 10 | Case Reports | 968 | Copyright © October 2026
Chronic radiation dermatitis (CRD) is a long-term complication of radiation therapy, typically manifesting as scarred atrophic plaques with telangiectasias. In some cases, patients report persist...
Read MorePost-Inflammatory Hyperpigmentation in Skin of Color Patients With Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Features | 975 | Copyright © October 2026
Differences in Atopic Dermatitis Comorbidity and Treatment Patterns by Race
October 2026 | Volume 25 | Issue 10 | Editorials | 978 | Copyright © October 2026
Assessing the Variability of Dermatologic Needs in American Indian/Alaskan Native Populations: A Single-Center Retrospective Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e59 | Copyright © October 2026
Atopic Dermatitis Flare Following Initiation of Nemolizumab
August 2026 | Volume 25 | Issue 8 | Case Reports | 751 | Copyright © August 2026
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by intense pruritus and episodic flares. While nemolizumab, an interleukin-31 (IL-31) inhibitor,...
Read MoreAssessing Accuracy of ChatGPT in Identifying Contact Allergens in Commonly Prescribed Topical Therapies for Psoriasis
August 2026 | Volume 25 | Issue 8 | Editorials | 758 | Copyright © August 2026
Update on Granulomatous Dermatoses: Clinical Features and Therapeutic Advances
June 2026 | Volume 25 | Issue 6 | Features | 580 | Copyright © June 2026
Treatment of Seborrheic Dermatitis and Post-Inflammatory Hypopigmentation With Roflumilast Foam in Skin of Color Patients
June 2026 | Volume 25 | Issue 6 | Features | 572 | Copyright © June 2026
Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK inhibitors used in Tandem for Treatment-Resistant Cases
June 2026 | Volume 25 | Issue 6 | Features | 569 | Copyright © June 2026
Treatment or Trigger? The Use of Biologic Therapy for Alopecia Areata
May 2026 | Volume 25 | Issue 5 | Features | 489 | Copyright © May 2026
Beyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
April 2026 | Volume 25 | Issue 4 | Original Article | 338 | Copyright © April 2026
Background: Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.Obje...
Read MoreExpert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema
March 2026 | Volume 25 | Issue 3 | Original Article | 228 | Copyright © March 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
